You are here: Industry Insights > COVID-19

News List

Positive early data from siltuximab COVID-19 trial pharmatimes
April 02, 2020
A third of patients with COVID-19 taking EUSA Pharma's interleukin (IL)-6 targeted monoclonal antibody siltuximab have experienced a clinical improvement, according to early findings from an observational case-control trial in Italy.
Aptorum to investigate use of repurposed drug candidates for coronavirus pharmaceutical-business-review
April 02, 2020
Aptorum Group has joined forces with Covar Pharmaceuticals for studying the use of three repurposed drug candidates for the treatment of novel coronavirus (COVID-19).
Beckman Coulter Announces Test Development for Coronavirus Antibodies americanpharmaceuticalreview
April 02, 2020
In response to the global COVID-19 pandemic, Beckman Coulter is developing assays to identify IgM and IgG antibodies to the coronavirus or SARS-CoV-2.
FibroGenesis Files Expanded Patent Coverage for Fibroblast Cell Therapy for COVID-19 ARDS americanpharmaceuticalreview
April 02, 2020
FibroGenesis announced the filing of United States Provisional Patent Number 63/002,134 titled, "Peptides and Adjuvants for Augmentation of Fibroblast Therapy for Coronavirus."
FDA and EMA offer updates on COVID-19 treatments and vaccines in development europeanpharmaceuticalreview
April 02, 2020
The FDA and EMA have announced which COVID-19 treatments and vaccines are currently in development, as well as how they are supporting clinical trials.
Accord to donate four million tablets to global COVID-19 prophylaxis trial europeanpharmaceuticalreview
April 02, 2020
The enterprise announced it will donate two million hydroxychloroquine tablets and the same of matched placebo to the multi-national COPCOV study.
How to take care of your mental health during the COVID-19 pandemic europeanpharmaceuticalreview
April 02, 2020
During the COVID-19 pandemic, when many are in lockdown or self-isolating, mental health could suffer. This article suggests some ways to stay healthy over this period.
FDA launches new programme to speed-up Covid-19 therapies pharmaceutical-technology
April 02, 2020
The US Food and Drug Administration (FDA) has launched a new programme aimed at accelerating the development of potential treatments for Covid-19 infection.
Neurimmune and Ethris to develop mRNA antibody for Covid-19 pharmaceutical-technology
April 02, 2020
Swiss biopharmaceutical firm Neurimmune has partnered with German biotechnology company Ethris to develop mRNA-based, neutralising antibodies for a Covid-19 therapeutic formulated for inhalation.
VBI Vaccines to develop pan-coronavirus vaccine pharmaceutical-technology
April 02, 2020
VBI Vaccines has partnered with the National Research Council of Canada (NRC) to create a pan-coronavirus vaccine candidate.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page